JFG
EFTRW

Jefferies Financial Group’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Jefferies Financial Group’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$1.64K – 2072
2022
Q4 		$1.64K Buy
+10,000
New +$1.39K ﹤0.01% 1500

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jefferies Financial Group's EFTRW Position: Q1 2023 in Review

Jefferies Financial Group sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q1 2023, closing a stake of 10,000 shares — an estimated $1.64K sold.

Jefferies Financial Group first reported a position in EFTRW in Q4 2022 and held it in 1 quarter. The position peaked at $1.64K in Q4 2022. 11 funds tracked by Wall St. Rank hold EFTRW as of Q1 2023.

  • Jefferies Financial Group reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 10,000 eFFECTOR Therapeutics, Inc. Warrant shares in Q1 2023, an estimated $1.64K.
  • Jefferies Financial Group first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q4 2022 and held it in 1 quarter.
  • Jefferies Financial Group's eFFECTOR Therapeutics, Inc. Warrant position peaked at $1.64K in Q4 2022.
  • 11 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q1 2023.

Based on Jefferies Financial Group's 13F filing for Q1 2023, filed 15 May 2023.